Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of Atazanavir and Raltegravir as Dual Strategy
2009-014656-30Phase 4Completed
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of atazanavir and raltegravir in human immunodeficiency virus infection (HIV), sponsored by Papa Giovanni XXIII Hospital. Primary endpoint: Persistence of virological efficacy. Started Jul 2009; status: completed.
02
Drugs
atazanavirraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-014656-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014656-30.